戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  PTEN influences its stability through OTUD3 deubiquitinase.
2 ith concomitantly reduced affinity for other deubiquitinases.
3 d function in a protein complex with histone deubiquitinases.
4  the chromatin binding and activities of the deubiquitinases.
5 o form of USP7, which differs from other USP deubiquitinases.
6  ubiquitin-specific protease (USP) family of deubiquitinases.
7 mulation with proinflammatory cytokines, the deubiquitinase A20 inducibly interacts with the regulato
8 pendent, noncatalytic mechanism by which the deubiquitinase A20 inhibits IkappaB kinase and NF-kappaB
9  PTEN, the signaling inhibitor SOCS1 and the deubiquitinase A20.
10 mulation of IKKgamma deubiquitination by the deubiquitinases A20 and CYLD (cylindromatosis).
11 rotease 9X (USP9X) is by far the most active deubiquitinase acting on Ub-PEX5, both in female rat liv
12 described here will be useful in identifying deubiquitinases acting on other ubiquitin conjugates.
13 ors or confer differential susceptibility to deubiquitinase activities associated with each pathway.
14 ying complex possesses acetyltransferase and deubiquitinase activities.
15 e depending on opposing ubiquitin ligase and deubiquitinase activities.
16 r phosphorylation directly regulates VCIP135 deubiquitinase activity and Golgi membrane fusion in the
17  which is accompanied by the recovery of its deubiquitinase activity and Golgi reassembly.
18 rylation of CYLD at serine 418 decreases its deubiquitinase activity and is necessary for IKKepsilon-
19 dies reveal molecular mechanisms whereby A20 deubiquitinase activity and ubiquitin binding, linear ub
20             The PCP domain was shown to have deubiquitinase activity for both RIG-I and TBK-1, whose
21                                 However, the deubiquitinase activity for stabilizing Tip60 is unknown
22 o underscores the biological significance of deubiquitinase activity in MSC function.
23 y reported effectors, such as the unexpected deubiquitinase activity in Xanthomonas XopD, contributed
24 d's incorporation into the proteasome, Rpn11 deubiquitinase activity is inhibited to prevent unwarran
25                                          The deubiquitinase activity is involved in the stabilization
26                                         USP7 deubiquitinase activity is required for the stabilizatio
27 ermore, small-molecule inhibitors of HAUSP's deubiquitinase activity markedly suppress the growth of
28                  This interaction allows the deubiquitinase activity of ataxin 3 to protect beclin 1
29 nuclear factor-kappaB activation through its deubiquitinase activity or by degradation of mRNA encodi
30 n this modular complex, Ataxin-7 anchors the deubiquitinase activity to the larger complex.
31 8R) in a case that completely abolished BAP1 deubiquitinase activity was identified.
32         A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protei
33 gative regulator of NF-kappaB signaling with deubiquitinase activity, is highly expressed in label-re
34 GE mobility shift of the protein, blocks its deubiquitinase activity, promotes its dissociation from
35 l kinase inhibitors, directly inhibits Usp9x deubiquitinase activity, resulting in the down-regulatio
36 ds plant chromatin and has enzymatic histone deubiquitinase activity, specific for the H2B histone.
37 bilities, as well as RNase activity, but not deubiquitinase activity, which impaired the inhibitory a
38 uate ubiquitin binding and thus inhibit USP7 deubiquitinase activity.
39  two juxtaposed helices critical to ataxin-3 deubiquitinase activity.
40  H2O2, revealing a new mechanism to regulate deubiquitinase activity.
41      A20 restricts NF-kappaB signals via its deubiquitinase activity.
42  into the proteasome as well as a C-terminal deubiquitinase adaptor (DEUBAD) domain that binds the de
43 head (winged-helix) DNA-binding domain and a deubiquitinase adaptor domain shared with two regulators
44 was examined and it was discovered that some deubiquitinases also possess derubylase activity.
45 y obstacle in delineating the impact between deubiquitinase and deISGylase activities on viral host e
46 e (PLpro) that has been observed to act as a deubiquitinase and deISGylase to antagonize type I inter
47 ptidase 49 (USP49) as a histone H2B-specific deubiquitinase and demonstrate that H2B deubiquitination
48                                 A20 contains deubiquitinase and E3 ligase domains and thus has been p
49 RF1 and suggest that the association between deubiquitinase and E3 ligase may serve as a common strat
50 e deISGylase activity but retained wild-type deubiquitinase and peptide cleavage activities.
51 vity with no appreciable impact on its other deubiquitinase and peptide cleavage biochemical properti
52 east, where loss of Ataxin-7 inactivates the deubiquitinase and results in increased H2B ubiquitinati
53 nd implements M2 polarization using both its deubiquitinase and RNase activities that cause sequentia
54 y identifies USP49 as a histone H2B-specific deubiquitinase and uncovers a critical role for H2B deub
55  a synthetic lethal screen with a library of deubiquitinases and identify USP39, which encodes an ess
56        Our work highlights the plasticity of deubiquitinases and indicates that new conformational st
57                                              Deubiquitinases and the ubiquitin/proteasome components
58                               Ovarian tumour deubiquitinases are cysteine proteases that cleave polyu
59                                              Deubiquitinases are important components of the protein
60                                              Deubiquitinases are proteases with a wide functional div
61              Here we find that Ubp2 and Ubp3 deubiquitinases are required for the proteasomal degrada
62             Here we show that ovarian tumour deubiquitinases are susceptible to reversible oxidation
63 977 melanoma cases and 754 controls and used deubiquitinase assays, a pedigree analysis, and a histop
64                                      The two deubiquitinases associate more with Rsp5 upon heat-stres
65  enhancing binding and activity of the USP16 deubiquitinase at transcribed genes.
66 olyglutamine (polyQ) repeat expansion in the deubiquitinase ataxin-3 causes neurodegeneration in Spin
67 re generated in situ by aggregate-associated deubiquitinase ataxin-3.
68 stinct pathways; an important example is the deubiquitinase ataxin3, which collaborates with p97 in e
69  We report that in addition to inhibition of deubiquitinases, b-AP15 inhibits the selenoprotein thior
70 the important tumour suppressor protein, the deubiquitinase BAP1.
71          USP2a is a member of a subfamily of deubiquitinases, called ubiquitin-specific cysteine prot
72                       Here we reveal how the deubiquitinase Cezanne (also known as OTUD7B) specifical
73                                          The deubiquitinase cezanne is a direct target of miR-218 and
74      A compensatory upregulation of Usp24, a deubiquitinase closely related to Usp9x, in Usp9x KD cel
75  establish the druggability of the USP1/UAF1 deubiquitinase complex and its potential as a molecular
76 onally interacted with the constituents of a deubiquitinase complex consisting of USP22, ATXN7, and A
77 s BAP1 and ASXL1 interact to form a polycomb deubiquitinase complex that removes monoubiquitin from h
78 SXL1 is the obligate regulatory subunit of a deubiquitinase complex whose catalytic subunit is BAP1.
79 removed by BRISC, an ABRO1/BRCC36-containing deubiquitinase complex.
80                               Ovarian tumour deubiquitinases comprise a family of fourteen human enzy
81 Here, we show that Leon, the Drosophila USP5 deubiquitinase, controls postsynaptic growth.
82              Because high levels of the USP8 deubiquitinase correlated with high levels of FLIP(S) ub
83 uitin chain assembly complex (LUBAC) and the deubiquitinase CYLD (cylindromatosis).
84                                          The deubiquitinase CYLD acts as a key negative regulator to
85 iquitin-editing enzyme A20 (TNFAIP3) and the deubiquitinase CYLD are central negative regulators of N
86  Here we demonstrate that E3 ligase Itch and deubiquitinase Cyld formed a complex via interaction thr
87 re we report that silencing of the lysine 63 deubiquitinase CYLD increases HIV transcription in an NF
88            Conversely, knockdown of the RIP1 deubiquitinase CYLD inhibited these functions.
89                    Here we show that loss of deubiquitinase CYLD led to the development of lung fibro
90 es CARMA1 and is negatively regulated by the deubiquitinase CYLD.
91         We report here that silencing of the deubiquitinase cylindromatosis protein (CYLD), increases
92 t was inserted into the EVG genome encodes a deubiquitinase/deISGylase and potentially suppresses hos
93 tations in the A20 ovarian tumour (OTU)-type deubiquitinase domain or in the zinc finger-4 (ZnF4) ubi
94  requiring MCPIP1's endoribonuclease but not deubiquitinase domain.
95 ch house histone acetyltransferase (HAT) and deubiquitinase (DUB) activities.
96  b-AP15 and its derivatives block proteasome deubiquitinase (DUB) activity and have been developed an
97 vity blocks oogenesis, while loss of the H2B deubiquitinase (DUB) activity does not.
98                                Inhibition of deubiquitinase (DUB) activity is a promising strategy fo
99       Interestingly, an MHV68 mutant lacking deubiquitinase (DUB) activity, embedded within the large
100                                          The deubiquitinase (DUB) and tumor suppressor BAP1 catalyzes
101                           A20 possesses both deubiquitinase (DUB) and ubiquitin E3 ligase activities
102 frequently mutated in cancer, functions as a deubiquitinase (DUB) for histone H2A.
103 e [poly(Q)] tract in ATXN7, a subunit of the deubiquitinase (DUB) module (DUBm) in the SAGA complex.
104 atalytic domain of herpes simplex virus UL36 deubiquitinase (DUb) to the N-terminal RING domain of rh
105                                          The deubiquitinase (DUB) Ubp10 is thought to promote heteroc
106                            We identified the deubiquitinase (DUB) Ubp7 as a late-arriving endocytic p
107        Recent evidence suggests that several deubiquitinases (DUB) are overexpressed or activated in
108  in regulation of the UPS involves targeting deubiquitinases (DUB).
109               Mechanistically, we identify a deubiquitinase, DUB3, as a target of CDK4/6; CDK4/6-medi
110 position on substrate, and susceptibility to deubiquitinases (DUBs) affect processing of different su
111                                              Deubiquitinases (DUBs) are a new class of drug targets,
112 , and both 20S proteasome peptidases and 19S deubiquitinases (DUBs) are becoming attractive targets o
113                                              Deubiquitinases (DUBs) are key regulators of Ub signalin
114                                              Deubiquitinases (DUBs) are proteases that regulate vario
115    Recent findings implicate ERAD-associated deubiquitinases (DUBs) as positive and negative regulato
116 ide bond is processed to a similar extent by deubiquitinases (DUBs) as that of a native Nepsilon-Gly-
117                   There are approximately 90 deubiquitinases (DUBs) encoded in the human genome, of w
118           Sixteen ovarian tumor (OTU) family deubiquitinases (DUBs) exist in humans, and most members
119 lysines, which can be antagonized by various deubiquitinases (DUBs) including the CYLD tumour suppres
120 hibition of UPS components, particularly key deubiquitinases (DUBs) of the ubiquitin-specific proteas
121                                              Deubiquitinases (DUBs) play an important role in regulat
122                                              Deubiquitinases (DUBs) remove ubiquitin conjugates from
123                               In eukaryotes, deubiquitinases (DUBs) remove ubiquitin conjugates from
124                                              Deubiquitinases (DUBs) reverse ubiquitin signals with eq
125 ormations, and ubiquitin-binding domains and deubiquitinases (DUBs) select pre-existing conformations
126  studies is that ubiquitin ligases (E3s) and deubiquitinases (DUBs), enzymes with opposing activities
127 B2 NZF Ub binding domain (UBD), 10 out of 12 deubiquitinases (DUBs), including USP8, USP15 and USP30,
128 e specificities of two proteasome-associated deubiquitinases (DUBs), Rpn11 and Ubp6, and explored the
129 us stages, including through its reversal by deubiquitinases (DUBs).
130 ts are well known, as are a variety of viral deubiquitinases (DUBs).
131   Removal of ubiquitin chains is mediated by deubiquitinases (DUBs).
132 ng catalyzed by a family of enzymes known as deubiquitinases (DUBs).
133 emoval of ubiquitin by ubiquitin ligases and deubiquitinases (DUBs).
134 d is reversed by a class of enzymes known as deubiquitinases (DUBs).
135 is tumor-suppressor protein), a K63-specific deubiquitinase enriched in postsynaptic densities, cleav
136 mplex, comprised of the E3 ligase Nrdp1, the deubiquitinase enzyme USP8, and Clec16a, a mediator of b
137 in-specific peptidase 9, X-linked (USP9X), a deubiquitinase enzyme, binds ERG in VCaP prostate cancer
138                       With TLR ligation, the deubiquitinase enzyme, STAM-binding protein (STAMBP) imp
139                        It can be reversed by deubiquitinase enzymes (DUBs) that remove ubiquitin moie
140                                              Deubiquitinase enzymes cleave ubiquitin from substrates
141 an and colleagues identify a sixth family of deubiquitinase enzymes that are highly conserved through
142 Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activ
143 iated cellular complexes, and identified the deubiquitinase FAM/USP9X as a novel interacting protein
144 In this study, we identified a member of the deubiquitinases family, ubiquitin-specific protease 18 (
145 direct antagonism between an E3 ligase and a deubiquitinase, Fbw7 and Usp28, in modulating intestinal
146 brary, we have identified USP2 as a specific deubiquitinase for cyclin D1.
147 S holoenzyme, which ultimately activates the deubiquitinase for substrate degradation.
148  study identifies USP12 and USP46 as histone deubiquitinases for H2A and H2B and reveals that USP12 r
149 how here that CYLD, a tumour suppressor with deubiquitinase function, has a pivotal and cell-intrinsi
150 clear which of the several counteracting H2A deubiquitinases functions along with PRC1 to control H2A
151 on by either lysine mutations or fusion of a deubiquitinase hampers NE-derived vesicle formation and
152 nd to the N-terminal TRAF-like region of the deubiquitinase HAUSP (herpesvirus-associated ubiquitin-s
153 ecently, an increasing number of histone H2A deubiquitinases have been identified and characterized.
154                                              Deubiquitinases hydrolyse ubiquitin modifications from p
155                                    USP7 is a deubiquitinase implicated in destabilizing the tumor sup
156 n IL-2 signaling and reduced expression of a deubiquitinase important for FOXP3 stability.
157 ene targeting approach to knockout (KO) this deubiquitinase in chicken DT40 cells.
158      The potential inclusion of such a novel deubiquitinase in the emerging anti-inflammatory strateg
159 e activities, revealing K63-linkage-specific deubiquitinases in human pathogens, such as Salmonella,
160 protease 14 (Usp14), a proteasome-associated deubiquitinase, in direct Ag presentation using a ligand
161  it stabilizes c-IAPs in vivo mainly through deubiquitinase-independent mechanisms.
162  related to enhanced expression of the USP22 deubiquitinase induced by c-MYC, leading to reduced SIRT
163  in vitro and in vivo, whereas a gradient of deubiquitinase inhibition promotes axon turning in vitro
164                           Treatment with the deubiquitinase inhibitor PR-619 increased caspase-8 ubiq
165   Taken together, our data indicate that the deubiquitinase inhibitor WP1130 increases bacterial kill
166  we found that the partially selective Usp9x deubiquitinase inhibitor WP1130 induced apoptosis and re
167  suggests opportunities for developing other deubiquitinase inhibitors and may be a strategy more bro
168                However, developing selective deubiquitinase inhibitors has been challenging and no co
169 mational dynamics are critical for ubiquitin-deubiquitinase interactions and imply that the fine tuni
170                                   USP9X is a deubiquitinase involved in multiple signaling and surviv
171 tors is central to Hh signaling, but whether deubiquitinase is involved in this process remains unkno
172 ed; however, it is unknown whether and how a deubiquitinase is involved.
173                             The BAP1 nuclear deubiquitinase is known to target histones (together wit
174 egulatory factor 1 (IRF1), suggesting that a deubiquitinase is recruited during gene activation.
175                  The BAP1 protein, a nuclear deubiquitinase, is inactivated in 15% of clear cell RCCs
176 tment with a small molecule inhibitor of the deubiquitinase (IU1) increased receptor ubiquitination.
177 tion affecting the catalytic site within the deubiquitinase JAB1/MPN/Mov34 (JAMM)/MPN domain.
178 ice, we identified cylindromatosis (CYLD), a deubiquitinase known to act directly on RIP1 and promote
179                      We report that USP28, a deubiquitinase known to be inhibitable by Ni(II) or hypo
180 ction in euploid cells, and deletion of this deubiquitinase leads to further proteasome-mediated prot
181                                    Thus, the deubiquitinase Leon maintains ubiquitin homeostasis and
182 biquitinated cyclin D1 as a substrate with a deubiquitinase library, we have identified USP2 as a spe
183 talytic domain related in fold to Ulp family deubiquitinase-like enzymes and a C-terminal PI3P-bindin
184                 Here we report that USP30, a deubiquitinase localized to mitochondria, antagonizes mi
185 sease, indicating that ubiquitin ligases and deubiquitinases maintain the delicate balance between ef
186 he Spt-Ada-Gcn5 acetyltransferase (SAGA) H2B deubiquitinase module competes with Bre1 for binding to
187 chanism in vivo, we found that a recombinant deubiquitinase module is active in the absence of Ataxin
188                                              Deubiquitinase MYSM1 has been shown to play a critical r
189  Immunity, Jiang et al. demonstrate that the deubiquitinase MYSM1 is part of an epigenetic switch tha
190 this study, we revealed that the histone H2A deubiquitinase MYSM1 plays an essential and intrinsic ro
191 on of NK cell development by the histone H2A deubiquitinase MYSM1 through the transcriptional control
192 ) mouse model, we identified the histone H2A deubiquitinase Mysm1, as a critical regulator in DC diff
193 found that mice deficient in the histone H2A deubiquitinase MYSM1, despite their severe defect in B c
194 mpaired in mice deficient in the histone H2A deubiquitinase MYSM1.
195  the protein stability of USP28, a bona fide deubiquitinase of LSD1.
196 iquitin carboxyl-terminal hydrolase (UCH) L5 deubiquitinases of the 19S proteasome that shows antitum
197 e reversal of this reaction by the USP1:UAF1 deubiquitinase only occurs when DNA is disengaged.
198 rulence factors that function as E3 ligases, deubiquitinases or as enzymes that directly attack ubiqu
199 acterial effector proteins with deSUMOylase, deubiquitinase, or, even, acetyltransferase activities.
200      We identify an Arabidopsis otubain-like deubiquitinase OTLD1 which directly interacts with the A
201             Here, we show that an OTU domain deubiquitinase, OTUD4, is a positive regulator of ALKBH2
202                  Here we have identified the deubiquitinase OTUD7B as a pivotal regulator of the non-
203           Here, we show that the M1-specific deubiquitinase OTULIN is essential for preventing TNF-as
204 entified that the ovarian tumor (OTU) family deubiquitinase OTULIN specifically disassembles Met1-Ub.
205 naling, and its function is regulated by the deubiquitinases OTULIN and CYLD, which associate with th
206 ngle E3 ligase complex (LUBAC), one specific deubiquitinase (OTULIN) and a very few linear polyubiqui
207       In contrast to other characterized USP deubiquitinases, our results indicate that USP28 has a c
208                Here, we demonstrate that the deubiquitinase ovarian tumor domain containing ubiquitin
209 for the 19S-resident and degradation-coupled deubiquitinase Poh1 in TRIM21 neutralization, signaling,
210        To reveal how the polycomb repressive-deubiquitinase (PR-DUB) complex controls substrate selec
211              The tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-kappaB, MA
212                                              Deubiquitinases reduce polyubiquitin dwell times prefere
213 oncanonical mechanism by which an OTU family deubiquitinase regulates its substrates, and provides mu
214     Here we report that Usp16, a histone H2A deubiquitinase, regulates H2A deubiquitination and gene
215 nctions for this entire group of histone H2A deubiquitinases remain unknown.
216                                              Deubiquitinases remove ubiquitin from proteins, and thei
217                                              Deubiquitinases remove ubiquitin from substrates to prev
218                      By contrast, the OTUD7B deubiquitinase removes polyubiquitin chains from GbetaL
219 ctional RNAi screen and identified BAP1 as a deubiquitinase required for efficient assembly of the ho
220 D4, which encode a ubiquitin E3 ligase and a deubiquitinase, respectively, were found in three affect
221 6S proteasome, where they are removed by the deubiquitinase Rpn11 during ATP-dependent substrate degr
222 ination at and eviction from chromatin; as a deubiquitinase, specific to the antagonism of ubiquitin
223      Together, these results reveal that the deubiquitinase STAMBPL1 is a key regulator of Tax traffi
224 e presence of A20, an upstream Lys-63-linked deubiquitinase, strongly curtailed the ability of MLK3 t
225 h TIR domain signalosome formation; 2) major deubiquitinases such as A20, CYLD, and DUBA prevent asso
226 o protect polyubiquitin from the activity of deubiquitinases, such as ataxin-3, that are necessary fo
227 ed ubiquitin-specific protease 8 (USP8) as a deubiquitinase that down-regulates Smo ubiquitination.
228 l hydrolase, UCH-L1, is an abundant neuronal deubiquitinase that is associated with Parkinson's disea
229 entify the mechanism of secretion of TssM, a deubiquitinase that plays an integral role in regulating
230 e (RNAi) libraries, we identified USP47 as a deubiquitinase that prevents beta-catenin ubiquitination
231           We recently discovered OTULIN as a deubiquitinase that specifically cleaves Met1-linked pol
232 e encoding A20 to repress expression of this deubiquitinase that suppresses inflammatory NF-kappaB si
233  OTUD4 is a scaffold for USP7 and USP9X, two deubiquitinases that act directly on the AlkB proteins.
234                Ubiquitination is balanced by deubiquitinases that cleave polyubiquitin chains and opp
235 ified USP12 and USP46 as histone H2A and H2B deubiquitinases that regulate Xenopus development.
236 of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degrad
237                                              Deubiquitinases therefore play an important role in the
238 strated that USP21 acts as a bona fide RIG-I deubiquitinase to down-regulate antiviral response indep
239 finger (NZF1) domain of the K29/K33-specific deubiquitinase TRABID specifically binds K29/K33-linked
240 ve Npl4 Zinc Finger 1 (NZF1) domain from the deubiquitinase TRABID to enrich for chains from human ce
241 llectively called 'Il23' here) involving the deubiquitinase Trabid.
242 K1 in the context of NASH, we identified the deubiquitinase tumor necrosis factor alpha-induced prote
243                       We have identified the deubiquitinase Ubiquitin Specific Protease-7 (USP7) as a
244                    Rather, we identified the deubiquitinase ubiquitin-specific peptidase 9X (USP9X) a
245 e ubiquitin pathway add (ligases) or remove (deubiquitinases) ubiquitin tags to or from their target
246       Here, we show that disruption of yeast deubiquitinase UBP3 leads to enhanced UV resistance, inc
247                                          The deubiquitinase Ubp3, which was identified by a genome-wi
248 ontrast, another UBL-containing protein, the deubiquitinase Ubp6, is also anchored by Rpn1, yet it di
249                 The Saccharomyces cerevisiae deubiquitinase Ubp7 has been characterized previously as
250        Sumoylation of Smo in turn recruits a deubiquitinase UBPY/USP8 to antagonize Smo ubiquitinatio
251 hanistically, in response to DNA damage, the deubiquitinase UCHL3 is phosphorylated and activated by
252 ermediates, we show that many ovarian tumour deubiquitinases undergo reversible oxidation upon treatm
253  and can be mediated through the loss of the deubiquitinase USP1.
254                                          The deubiquitinase USP10 specifically removes ubiquitination
255 NEMO ubiquitylation is decreased through the deubiquitinase USP10, which interacts with NEMO via MCPI
256  Huwe1 activity on TBP is antagonized by the deubiquitinase USP10, which protects TBP from degradatio
257 ugh Notch/Hey1-induced repression of the PML deubiquitinase USP11 and suggests an important role for
258 ical analyses of an evolutionarily conserved deubiquitinase, USP12, which is activated by two beta-pr
259                        Here we report that a deubiquitinase, USP13, regulates DDR by targeting RAP80.
260  of ML364, a small molecule inhibitor of the deubiquitinase USP2 and its use to interrogate the biolo
261  E3 ligase Nedd4 and deubiquitination by the deubiquitinases USP20 and USP33 have been shown to regul
262 ligase, and promoted the dissociation of the deubiquitinases USP20 and USP33.
263                   Here we report that the E3 deubiquitinase USP21 prevents the depletion of FOXP3 at
264               Functional comparison of three deubiquitinases (USP21, A20, and CYLD) demonstrated that
265                                          The deubiquitinase USP28 stabilizes oncogenic factors, inclu
266  encoding the p53-binding protein 53BP1, the deubiquitinase USP28, and the ubiquitin ligase TRIM37.
267          This activity is antagonized by the deubiquitinase Usp28, which is highly expressed in murin
268             Recently, we have identified the deubiquitinase USP37 as a regulator of the cell cycle.
269                             We show that the deubiquitinase USP37 binds CDH1 and removes degradative
270                                          The deubiquitinase USP44 was identified as a key regulator o
271              In this study, we show that the deubiquitinase USP46 stabilizes the expression of both P
272                        Here we report that a deubiquitinase, USP49, is a new regulator of the AKT pat
273 ion elongation factor Elongin BC and the H2B deubiquitinase USP7 to modulate transcriptional processe
274 BP1 by accelerating its interaction with the deubiquitinase USP7.
275 ort that PHF8 physically associates with the deubiquitinase USP7.
276 f CHMP5 by inducing its interaction with the deubiquitinase USP8.
277 content and pathological localization of the deubiquitinase Usp8.
278  Drosophila model, unlike knockdown of other deubiquitinases, Usp8 protected from alpha-synuclein-ind
279  our data describe the identification of the deubiquitinase USP9X as a novel mTORC1 and -2 binding pa
280 ere, we define a cell intrinsic role for the deubiquitinase Usp9X during proximal TCR signaling.
281 anner, we found that loss of function in the deubiquitinase USP9X prevented proliferation arrest by t
282 a, the E3 ligases MULE and betaTrCP, and the deubiquitinase USP9x regulate cytokine-mediated MCL-1 pr
283                        Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promote
284  most commonly mutated gene was the X-linked deubiquitinase Usp9x, which was inactivated in over 50%
285  in early mitosis and deubiquitinated by the deubiquitinase VCIP135 in late mitosis.
286 nsisting of the HECT E3 ligase UBE3C and the deubiquitinase vOTU.
287 s and His box motifs conserved in eukaryotic deubiquitinases, was purified and biochemically characte
288 uggesting that Ub-PEX5 is also a target of a deubiquitinase were also obtained in that work.
289       We identify Dub3 as a bona fide Snail1 deubiquitinase, which interacts with and stabilizes Snai
290 release requires cooperation of Cdc48 with a deubiquitinase, which trims polyubiquitin to an oligoubi
291 s identified Usp16 as one of the histone H2A deubiquitinases, which coordinates with the H2A ubiquiti
292                            USP7 is a protein deubiquitinase with an essential role in development.
293   Mysm1 is a recently identified histone H2A deubiquitinase with essential and intrinsic roles for ma
294 on mutations in OTULIN (FAM105B), encoding a deubiquitinase with linear linkage specificity.
295 domain revealed high similarity to mammalian deubiquitinases with a unique alpha-helix close to the s
296  review, we focus on NF-kappaB regulation by deubiquitinases with an emphasis on A20 and CYLD.
297                  2c inhibited representative deubiquitinases with micromolar IC50, and its proapoptot
298 nts exhibit increased affinity for the USP14 deubiquitinase, with concomitantly reduced affinity for
299 e processing and is accomplished by Rpn11, a deubiquitinase within the 'lid' sub-complex.
300  enzymatic activities with two mitochondrial deubiquitinases, yeast ScUBP16 and human HsUSP30, which

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top